Annual D&A
$352.00 K
-$215.00 K-37.92%
December 31, 2024
Summary
- As of February 26, 2025, APVO annual depreciation & amortization is $352.00 thousand, with the most recent change of -$215.00 thousand (-37.92%) on December 31, 2024.
- During the last 3 years, APVO annual D&A has fallen by -$792.00 thousand (-69.23%).
- APVO annual D&A is now -89.53% below its all-time high of $3.36 million, reached on December 31, 2016.
Performance
APVO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$71.00 K
-$13.00 K-15.48%
December 31, 2024
Summary
- As of February 26, 2025, APVO quarterly depreciation & amortization is $71.00 thousand, with the most recent change of -$13.00 thousand (-15.48%) on December 31, 2024.
- Over the past year, APVO quarterly D&A has stayed the same.
- APVO quarterly D&A is now -94.43% below its all-time high of $1.27 million, reached on September 30, 2017.
Performance
APVO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$352.00 K
-$45.00 K-11.34%
December 31, 2024
Summary
- As of February 26, 2025, APVO TTM depreciation & amortization is $352.00 thousand, with the most recent change of -$45.00 thousand (-11.34%) on December 31, 2024.
- Over the past year, APVO TTM D&A has stayed the same.
- APVO TTM D&A is now -90.54% below its all-time high of $3.72 million, reached on September 30, 2016.
Performance
APVO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
APVO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.9% | 0.0% | 0.0% |
| 3 y3 years | -69.2% | 0.0% | 0.0% |
| 5 y5 years | -84.3% | 0.0% | 0.0% |
APVO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.2% | at low | -74.3% | at low | -69.2% | at low |
| 5 y | 5-year | -84.3% | at low | -86.7% | at low | -84.3% | at low |
| alltime | all time | -89.5% | at low | -94.4% | at low | -90.5% | at low |
Aptevo Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $352.00 K(-37.9%) | $71.00 K(-15.5%) | $352.00 K(-11.3%) |
| Sep 2024 | - | $84.00 K(-7.7%) | $397.00 K(-8.9%) |
| Jun 2024 | - | $91.00 K(-14.2%) | $436.00 K(-11.9%) |
| Mar 2024 | - | $106.00 K(-8.6%) | $495.00 K(-12.7%) |
| Dec 2023 | $567.00 K(-37.1%) | $116.00 K(-5.7%) | $567.00 K(-7.4%) |
| Sep 2023 | - | $123.00 K(-18.0%) | $612.00 K(-13.9%) |
| Jun 2023 | - | $150.00 K(-15.7%) | $711.00 K(-15.1%) |
| Mar 2023 | - | $178.00 K(+10.6%) | $837.00 K(-7.1%) |
| Dec 2022 | $901.00 K(-21.2%) | $161.00 K(-27.5%) | $901.00 K(-9.5%) |
| Sep 2022 | - | $222.00 K(-19.6%) | $996.00 K(-6.8%) |
| Jun 2022 | - | $276.00 K(+14.0%) | $1.07 M(-2.1%) |
| Mar 2022 | - | $242.00 K(-5.5%) | $1.09 M(-4.5%) |
| Dec 2021 | $1.14 M(-18.6%) | $256.00 K(-13.2%) | $1.14 M(-7.0%) |
| Sep 2021 | - | $295.00 K(-1.3%) | $1.23 M(-0.4%) |
| Jun 2021 | - | $299.00 K(+1.7%) | $1.24 M(-0.8%) |
| Mar 2021 | - | $294.00 K(-14.0%) | $1.25 M(-11.5%) |
| Dec 2020 | $1.41 M(-37.1%) | $342.00 K(+14.0%) | $1.41 M(-12.0%) |
| Sep 2020 | - | $300.00 K(-2.9%) | $1.60 M(-13.3%) |
| Jun 2020 | - | $309.00 K(-32.1%) | $1.84 M(-12.5%) |
| Mar 2020 | - | $455.00 K(-14.6%) | $2.11 M(-5.7%) |
| Dec 2019 | $2.23 M | $533.00 K(-2.4%) | $2.23 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $546.00 K(-4.7%) | $2.31 M(-2.2%) |
| Jun 2019 | - | $573.00 K(-1.7%) | $2.36 M(-1.1%) |
| Mar 2019 | - | $583.00 K(-3.8%) | $2.39 M(-0.2%) |
| Dec 2018 | $2.39 M(-23.6%) | $606.00 K(+1.5%) | $2.39 M(+24.5%) |
| Sep 2018 | - | $597.00 K(-0.5%) | $1.92 M(-26.1%) |
| Jun 2018 | - | $600.00 K(+2.2%) | $2.60 M(-9.6%) |
| Mar 2018 | - | $587.00 K(+331.6%) | $2.87 M(-8.1%) |
| Dec 2017 | $3.13 M(-7.0%) | $136.00 K(-89.3%) | $3.13 M(-9.1%) |
| Sep 2017 | - | $1.27 M(+45.7%) | $3.44 M(+2.4%) |
| Jun 2017 | - | $875.00 K(+4.0%) | $3.36 M(-0.2%) |
| Mar 2017 | - | $841.00 K(+86.9%) | $3.37 M(+0.1%) |
| Dec 2016 | $3.36 M(+15.7%) | $450.00 K(-62.3%) | $3.36 M(-9.6%) |
| Sep 2016 | - | $1.20 M(+35.6%) | $3.72 M(+12.2%) |
| Jun 2016 | - | $881.00 K(+5.4%) | $3.32 M(+5.2%) |
| Mar 2016 | - | $836.00 K(+3.5%) | $3.15 M(+8.5%) |
| Dec 2015 | $2.91 M(+43.8%) | $808.00 K(+2.1%) | $2.91 M(+38.5%) |
| Sep 2015 | - | $791.00 K(+10.2%) | $2.10 M(+60.5%) |
| Jun 2015 | - | $718.00 K(+21.7%) | $1.31 M(+121.7%) |
| Mar 2015 | - | $590.00 K | $590.00 K |
| Dec 2014 | $2.02 M(+203.5%) | - | - |
| Dec 2013 | $666.00 K | - | - |
FAQ
- What is Aptevo Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual D&A year-on-year change?
- What is Aptevo Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly D&A year-on-year change?
- What is Aptevo Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM D&A year-on-year change?
What is Aptevo Therapeutics annual depreciation & amortization?
The current annual D&A of APVO is $352.00 K
What is the all time high annual D&A for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual depreciation & amortization is $3.36 M
What is Aptevo Therapeutics annual D&A year-on-year change?
Over the past year, APVO annual depreciation & amortization has changed by -$215.00 K (-37.92%)
What is Aptevo Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of APVO is $71.00 K
What is the all time high quarterly D&A for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly depreciation & amortization is $1.27 M
What is Aptevo Therapeutics quarterly D&A year-on-year change?
Over the past year, APVO quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Aptevo Therapeutics TTM depreciation & amortization?
The current TTM D&A of APVO is $352.00 K
What is the all time high TTM D&A for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM depreciation & amortization is $3.72 M
What is Aptevo Therapeutics TTM D&A year-on-year change?
Over the past year, APVO TTM depreciation & amortization has changed by $0.00 (0.00%)